Bahl & Gaynor’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $765M | Buy |
|
|||||
|
2025
Q1 | $691M | Sell |
|
|||||
|
2024
Q4 | $594M | Sell |
|
|||||
|
2024
Q3 | $668M | Buy |
|
|||||
|
2024
Q2 | $578M | Buy |
|
|||||
|
2024
Q1 | $600M | Sell |
|
|||||
|
2023
Q4 | $518M | Sell |
|
|||||
|
2023
Q3 | $515M | Sell |
|
|||||
|
2023
Q2 | $470M | Sell |
|
|||||
|
2023
Q1 | $644M | Buy |
|
|||||
|
2022
Q4 | $537M | Sell |
|
|||||
|
2022
Q3 | $470M | Buy |
|
|||||
|
2022
Q2 | $508M | Buy |
|
|||||
|
2022
Q1 | $423M | Sell |
|
|||||
|
2021
Q4 | $447M | Sell |
|
|||||
|
2021
Q3 | $364M | Buy |
|
|||||
|
2021
Q2 | $378M | Sell |
|
|||||
|
2021
Q1 | $364M | Buy |
|
|||||
|
2020
Q4 | $350M | Buy |
|
|||||
|
2020
Q3 | $270M | Buy |
|
|||||
|
2020
Q2 | $257M | Buy |
|
|||||
|
2020
Q1 | $148M | Buy |
|
|||||
|
2019
Q4 | $61.7M | Sell |
|
|||||
|
2019
Q3 | $60.3M | Sell |
|
|||||
|
2019
Q2 | $101M | Buy |
|
|||||
|
2019
Q1 | $84.2M | Sell |
|
|||||
|
2018
Q4 | $208M | Buy |
|
|||||
|
2018
Q3 | $175M | Sell |
|
|||||
|
2018
Q2 | $237M | Buy |
|
|||||
|
2018
Q1 | $227M | Sell |
|
|||||
|
2017
Q4 | $247M | Buy |
|
|||||
|
2017
Q3 | $188M | Buy |
|
|||||
|
2017
Q2 | $136M | Sell |
|
|||||
|
2017
Q1 | $149M | Buy |
|
|||||
|
2016
Q4 | $118M | Sell |
|
|||||
|
2016
Q3 | $143M | Sell |
|
|||||
|
2016
Q2 | $159M | Sell |
|
|||||
|
2016
Q1 | $149M | Buy |
|
|||||
|
2015
Q4 | $154M | Buy |
|
|||||
|
2015
Q3 | $129M | Buy |
|
|||||
|
2015
Q2 | $158M | Buy |
|
|||||
|
2015
Q1 | $137M | Buy |
|
|||||
|
2014
Q4 | $148M | Buy |
|
|||||
|
2014
Q3 | $128M | Buy |
|
|||||
|
2014
Q2 | $121M | Buy |
|
|||||
|
2014
Q1 | $106M | Buy |
|
|||||
|
2013
Q4 | $108M | Buy |
|
|||||
|
2013
Q3 | $70.9M | Buy |
|
|||||
|
2013
Q2 | $64.6M | Buy |
|